This Market Factors starts with a pair trade to keep upside from U.S. stocks while profiting from a potential AI investment ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva's anti-IL-15 candidate, TEV-'408 TE ...

Ben Lloyd explores the key challenges of employing AI in manufacturing and highlights how new plug-and-play solutions are ...

Heartland Town Centre expands with new tenants and strong sales, including a first-to-Canada family attraction and key ...

Some of the most significant changes include what GLP-1 users eat at restaurants. Technomic data shows that one-third of ...

This rye-based whisky made in the Scottish Highlands is good enough to win over the most skeptical American rye drinker.

Atlassian (TEAM) stock is down 25% on AI fears—see why its moat, switching costs, and 30% growth outlook may signal upside.

More than 1,500 people signed a petition to prevent a $2.99 processing fee if they automatically pay their DTE bills with a ...

Jarvis has led Princeton University Library through a decade of growth and transformation, redefining what a modern academic ...

Professional services company AON is expanding its insurance offering for datacentre developers and investors, citing the ...